Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 1
2019 1
2021 1
2022 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Cabazitaxel inhibits proliferation and potentiates the radiation response of U87MG glioblastoma cells.
Neshasteh-Riz A, Zeinizade E, Safa M, Mousavizadeh K. Neshasteh-Riz A, et al. Cell Biol Int. 2018 Jul;42(7):815-822. doi: 10.1002/cbin.10940. Epub 2018 Feb 14. Cell Biol Int. 2018. PMID: 29369439
Cabazitaxel is a second-generation semisynthetic taxane. The recognized anti-neoplastic effect of Cabazitaxel is cell cycle perturbation by inducing arrest at G2/M. ...Cabazitaxel enhanced the cytotoxicity response of U87MG cells to radiation. Apoptosis incre …
Cabazitaxel is a second-generation semisynthetic taxane. The recognized anti-neoplastic effect of Cabazitaxel is cell cycle pe …
All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
Wu S, Lu L, Zhou J, Ran D, Wang S, Xu Q, Xu W, Wang J, Liu Y, Xie C, Luo Z, Lu W. Wu S, et al. J Control Release. 2022 May;345:685-695. doi: 10.1016/j.jconrel.2022.03.047. Epub 2022 Mar 26. J Control Release. 2022. PMID: 35346767
Glioblastoma (GBM) is the most aggressive brain tumor with poor prognosis and frequent recurrence. ...Herein we developed an all-stage glioma-targeted cabazitaxel (CBZ) nanocrystal loaded liposome modified with a "Y" shaped targeting ligand composed of pHA and VAP ( …
Glioblastoma (GBM) is the most aggressive brain tumor with poor prognosis and frequent recurrence. ...Herein we developed an all-stag …
Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model.
Sulheim E, Mørch Y, Snipstad S, Borgos SE, Miletic H, Bjerkvig R, Davies CL, Åslund AKO. Sulheim E, et al. Nanotheranostics. 2019 Feb 7;3(1):103-112. doi: 10.7150/ntno.31479. eCollection 2019. Nanotheranostics. 2019. PMID: 30899638 Free PMC article.
Treatment of glioblastoma and other diseases in the brain is especially challenging due to the blood-brain barrier, which effectively protects the brain parenchyma. In this study we show for the first time that cabazitaxel, a semi-synthetic derivative of docetaxel c …
Treatment of glioblastoma and other diseases in the brain is especially challenging due to the blood-brain barrier, which effectively …
Hyaluronic Acid-Conjugated Nanoparticles for the Targeted Delivery of Cabazitaxel to CD44-Overexpressing Glioblastoma Cells.
Chen C, Fan R, Wang Y, Wang L, Huang C, Zhou L, Xu J, Chen H, Guo G. Chen C, et al. J Biomed Nanotechnol. 2021 Apr 1;17(4):595-605. doi: 10.1166/jbn.2021.3050. J Biomed Nanotechnol. 2021. PMID: 35057886
In decades, the efficiency of glioma therapy is far from satisfaction due to the inability of most therapeutics to accumulate at the glioblastoma (GBM) site. Therefore, it is urgent to develop novel tumor-targeted delivery systems for more optimized and effective glioma tr …
In decades, the efficiency of glioma therapy is far from satisfaction due to the inability of most therapeutics to accumulate at the glio …
Therapeutic efficacy to dose-dependent toxicity of Cabazitaxel in C6-induced glioblastoma model of rats.
Mohammadzadeh Z, Khaksari M, Nematollahi MH, Kheirandish R, Moslemizadeh A, Delshad S, Faramarz S, Tezerji SS, Torkashvand M, Shahba S, Bashiri H. Mohammadzadeh Z, et al. Toxicol Res (Camb). 2025 Apr 2;14(2):tfaf048. doi: 10.1093/toxres/tfaf048. eCollection 2025 Apr. Toxicol Res (Camb). 2025. PMID: 40182916
This study was designed to adjust effective chemotherapy doses of cabazitaxel (CBZ) on cognitive behaviors, inflammatory cytokines and oxidative stress parameters, and survival rate in C6-induced GBM of rats. ...
This study was designed to adjust effective chemotherapy doses of cabazitaxel (CBZ) on cognitive behaviors, inflammatory cytokines an …
Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
Sémiond D, Sidhu SS, Bissery MC, Vrignaud P. Sémiond D, et al. Cancer Chemother Pharmacol. 2013 Sep;72(3):515-28. doi: 10.1007/s00280-013-2214-x. Epub 2013 Jul 3. Cancer Chemother Pharmacol. 2013. PMID: 23820961
METHODS: Cabazitaxel brain distribution was assessed in mice, rats and dogs. Cabazitaxel antitumor activity was assessed in mice bearing intracranial human glioblastoma (SF295; U251) xenografts, and subcutaneous cell line-derived human pediatric sarcoma (rhab …
METHODS: Cabazitaxel brain distribution was assessed in mice, rats and dogs. Cabazitaxel antitumor activity was assessed in mi …
Dendrimer-Functionalized Nanodiamonds as Safe and Efficient Drug Carriers for Cancer Therapy: Nucleus Penetrating Nanoparticles.
Patil S, Mishra VS, Yadav N, Reddy PC, Lochab B. Patil S, et al. ACS Appl Bio Mater. 2022 Jul 18;5(7):3438-3451. doi: 10.1021/acsabm.2c00373. Epub 2022 Jun 27. ACS Appl Bio Mater. 2022. PMID: 35754387
Physical encapsulation of poorly water soluble cabazitaxel (CTX) drug on NP formed ND-PAMAM-CTX (NPC) nanoconjugates and substantially reduced the size of CTX from micrometer to nanometer. ...The present work highlights the potential of a newly designed nanocarrier NP as a …
Physical encapsulation of poorly water soluble cabazitaxel (CTX) drug on NP formed ND-PAMAM-CTX (NPC) nanoconjugates and substantiall …